(Q33521164)

27 July 2017

1 reference

title

Lofexidine, an {alpha}2-receptor agonist for opioid detoxification (English)

1 reference

27 July 2017

0 references

Emily C Gish

1

1 reference

27 July 2017

Jamie L Miller

series ordinal

2

1 reference

27 July 2017

Brooke L Honey

series ordinal

3

1 reference

27 July 2017

Peter N Johnson

series ordinal

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

29 December 2009

1 reference

Annals of Pharmacotherapy

27 July 2017

1 reference

27 July 2017

44

1 reference

27 July 2017

2

1 reference

27 July 2017

343-351

1 reference

Management of drug and alcohol withdrawal

27 July 2017

1 reference

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

21 January 2018

1 reference

Prison based detoxification for opioid dependence: a randomised double blind controlled trial of lofexidine and methadone

21 January 2018

1 reference

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

21 January 2018

1 reference

A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial

21 January 2018

1 reference

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

21 January 2018

1 reference

Lofexidine versus clonidine in rapid opiate detoxification

21 January 2018

1 reference

A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal

21 January 2018

1 reference

Lofexidine and opioid withdrawal

21 January 2018

1 reference

Clonidine blocks acute opiate-withdrawal symptoms

21 January 2018

1 reference

Pharmacokinetics of lofexidine hydrochloride in healthy volunteers

21 January 2018

1 reference

Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis

21 January 2018

1 reference

Urine and plasma pharmacokinetics of lofexidine after oral delivery in opiate-dependent patients.

21 January 2018

1 reference

In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.

21 January 2018

1 reference

QT interval increased after single dose of lofexidine

21 January 2018

1 reference

Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1M347

1 reference

release_opj5qqcgnndfdg3qdelmxxg6ay

27 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/opj5qqcgnndfdg3qdelmxxg6ay

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference